Caladrius Biosciences, Inc. (LSTA) Tops Q2 EPS by 10c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q2 EPS of ($0.54), $0.10 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• Suncrete Inc (RMIX) PT Lowered to $22 at Jefferies
• Apple revises EU app distribution terms, cuts fees and expands access